Abstract
Disparities in Frontline Treatment and Overall Survival in the Era of Targeted Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: 2004-2021
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have